EP3518897
OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOF
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.9.2017EP published:
9.2.2022EP application number:
17857601.3
EPO information:
European Patent Register
Max expiry date:
29.9.2037
Title in English:
OPHTHALMIC DRUG SUSTAINED RELEASE FORMULATION AND USES THEREOFLanguage of the patent:
English
Timeline
Today
30.9.2017EP application
9.2.2022EP Publication
Owner
Name:
Mati Therapeutics Inc.Address:
4317 Dunning Lane, Austin, TX 78746, US
Inventor
Name:
UTKHEDE, DeepankAddress:
Burnaby, British Columbia V5G 4X4, CA
Name:
JONES, CatherineAddress:
Burnaby, British Columbia V5G 4X4, CA
Name:
WISEMAN, DavidAddress:
Burnaby, British Columbia V5G 4X4, CA
Priority
Number:
201662402938 PDate:
30.9.2016Country:
US
Classification
Categories:
A61K 9/14, A61K 47/34, A61K 47/10, A61K 31/165, A61K 38/13, A61F 9/00, A61L 27/54